[Application of recombinant human activated protein C with blood product administration and deep vein thrombosis in severe sepsis].
Liu
Ling
L
Department of Critical Care Medicine, Zhongda Hospital and School of Clinical Medicine, Southeast University, Nanjing 210009, Jiangsu, China.
Guo
Feng-mei
FM
Qiu
Hai-bo
HB
D016913:Blood Component Transfusion; D006801:Humans; D011486:Protein C / Q000627:therapeutic use*; D018805:Sepsis / Q000150:complications / Q000628:therapy*; D020246:Venous Thrombosis / Q000209:etiology / Q000517:prevention & control*
D011486:Protein C